
CAS Number586966-54-3
Synonymstert-butyl (3R,5S,E)-7-(2-chloropropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Tert-butyl Pitavastatin; pitavastatin tert butyl ester; (3R,5S,6E)7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptaneacid,ethylester
Molecular FormulaC29H32FNO4
Molecular Weight477.58
Purity98.00%
Density1.2±0.1 g/cm3
Boiling Point674.5±55.0 °C at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 586966-54-3 |
| Catalog No. | 2A-9057635 |
| Chinese Name | 匹伐他汀叔丁酯 |
| Synonyms | tert-butyl (3R,5S,E)-7-(2-chloropropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; Tert-butyl Pitavastatin; pitavastatin tert butyl ester; (3R,5S,6E)7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptaneacid,ethylester |
| Molecular Formula | C29H32FNO4 |
| Molecular Weight | 477.58 |
| Purity | 98.00 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 674.5±55.0 °C at 760 mmHg |
| Storage Condition | 2-8℃, sealed, dry |
| Application | tert-Buthyl Pitavastatin is a metabolite of Pitavastatin. Pitavastatin is a potent HMG-CoA reductase inhibitor. |
| MDL Number | C29H32FNO4 |
| SMILES | CC(C)(C)OC(=O)CC(O)CC(O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1 |
| InChI Key | RCARMBIYAHBUHR-UQECUQMJSA-N |
| MSDS | msds/57635_1_586966_54_3.pdf |
| Transport Info | Product name: tert-Buthyl Pitavastatin |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Rosuvastatin-5S-lactone | 503610-43-3 | 2A-9057510 |
| Apixaban | 503612-47-3 | 2A-9057511 |
| Raltegravir | 518048-05-0 | 2A-9057542 |
| Telmisartan methyl ester | 528560-93-2 | 2A-9057567 |
| Sunitinib | 557795-19-4 | 2A-9057603 |
| Carvedilol phosphate hemihydrate | 610309-89-2 | 2A-9057706 |
| Sitagliptin phosphate monohydrate | 654671-77-9 | 2A-9057813 |
| Sitagliptin phosphate | 654671-78-0 | 2A-9057814 |
| Linagliptin | 668270-12-0 | 2A-0202309 |
| Neratinib | 698387-09-6 | 2A-9057939 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA